07-01-2026 12:45 via drugs.com

Ozempic, Wegovy Might Lower Colon Cancer Risk

WEDNESDAY, Jan. 7, 2026— Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.People who took a GLP-1 drug were 36% less likely to get colon cancer than people who took a...

Report Reveals Prevalence of Allergic Conditions in U.S. Adults, Children in 2024

Light Physical Activity May Lower Mortality Risk in Cardiovascular-Kidney-Metabolic Syndrome

Physical Design of Critical Care Units Influences Nursing Culture

Guidance Updated for Evaluation, Management of Refractory Constipation

Nestlé Recalls Baby Formula Over Toxin Risk

Adjunct Exercise May Aid Depression Symptoms

Preoperative Stress Tied to Postoperative Outcomes in Older Adults

Pregnant Women With COVID-19 Have Increased Risk for Complications

Significant Laboratory Costs Associated With Point-of-Care Hepatitis C Testing

Odds of Infant Mortality Higher Among U.S.-Born Than Non-U.S.-Born Individuals

Study Finds Rise in Chagas-Carrying Bugs Near U.S.-Mexico Border

GLP-1 Receptor Agonists Tied to Reduced Acute Asthma Exacerbations in Teens With Overweight, Obesity

FDA Misses Deadline to Ban Formaldehyde in Hair Straighteners

New U.S. Diet Guidelines Push Whole Foods, Meat and Dairy

Desktop versie

Ozempic, Wegovy Might Lower Colon Cancer Risk

Pharmaceutical news